Effectiveness and safety of polatuzumab vedotin combined with zuberitamab plus cyclophosphamide, doxorubicin and prednisone in untreated diffuse large B-cell lymphoma: A real-world study from China - Wei Li; Lanfang Li; Xianming Liu; Zhao Peiqi; Zhengzi Qian; Lihua Qiu; Shiyong Zhou; Huilai Zhang (Blood, 2025)